Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in PGEN — Precigen, Inc.

CIK 1000275 TORONTO, A6
Back to PGEN Full portfolio

Position in PGEN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$837,988
+$796,526 QoQ
Shares Held
147,016
+1272.2% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 210 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PGEN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. PGEN ranks #63 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in PGEN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $837,988 147,016
2026-03-31 $41,462 10,714
2025-12-31 $22,103 5,288
2025-09-30 $264,540 80,408
2025-06-30 $533,486 375,696
2025-03-31 $13,402 8,996
2024-12-31 $20,690 18,474
2024-09-30 $12,077 12,714
2024-06-30 $29,649 18,766
2024-03-31 $5,736 3,957
2023-12-31 $54,819 40,911
2023-09-30 $264,169 186,035
2023-06-30 $17,036 14,815
2023-03-31 $9,423 8,890
2022-12-31 $18,232 11,996
2022-09-30 $7,103 3,351
2022-06-30 $4,002 2,987
2022-03-31 $24,874 11,789
2021-12-31 $230,289 62,073
2021-09-30 $317,093 63,546
2021-06-30 $163,071 25,011
2021-03-31 $163,553 23,738
2020-12-31 $190,657 18,692
2020-09-30 $69,643 19,898
2020-06-30 $96,236 19,286
2020-03-31 $157,469 46,315